메뉴 건너뛰기




Volumn 110, Issue 2, 2006, Pages 175-178

Exercise urotensin II dynamics in myocardial infarction survivors with and without hypertension

Author keywords

Exercise; Hypertension; Myocardial infarction; Urotensin II

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE; UROTENSIN II;

EID: 33646772839     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.07.008     Document Type: Article
Times cited : (13)

References (15)
  • 1
    • 0031965547 scopus 로고    scopus 로고
    • Long-term prognosis after acute myocardial infarction in patients with a history of arterial hypertension
    • Gustafsson F., Kober L., Torp-Pedersen C., et al. Long-term prognosis after acute myocardial infarction in patients with a history of arterial hypertension. Eur Heart J 19 (1998) 588-594
    • (1998) Eur Heart J , vol.19 , pp. 588-594
    • Gustafsson, F.1    Kober, L.2    Torp-Pedersen, C.3
  • 3
    • 3042713965 scopus 로고    scopus 로고
    • Plasma concentration of urotensin II is raised in hypertension
    • Cheung B.M., Leung R., Man Y.B., and Wong L.Y. Plasma concentration of urotensin II is raised in hypertension. J Hypertens 22 (2004) 1341-1344
    • (2004) J Hypertens , vol.22 , pp. 1341-1344
    • Cheung, B.M.1    Leung, R.2    Man, Y.B.3    Wong, L.Y.4
  • 4
    • 0042525995 scopus 로고    scopus 로고
    • Direct actions of urotensin II on the heart - implications for cardiac fibrosis and hypertrophy
    • Tzanidis A., Hannan R.D., Thomas W.G., et al. Direct actions of urotensin II on the heart - implications for cardiac fibrosis and hypertrophy. Circ Res 93 (2003) 246-253
    • (2003) Circ Res , vol.93 , pp. 246-253
    • Tzanidis, A.1    Hannan, R.D.2    Thomas, W.G.3
  • 5
    • 0842266248 scopus 로고    scopus 로고
    • From 'gills to pills': urotensin II as a regulator of mammalian cardiorenal fuction
    • Douglas S.A., Dhanak D., and Johns D.G. From 'gills to pills': urotensin II as a regulator of mammalian cardiorenal fuction. Trends Pharmacol Sci 25 (2004) 77-85
    • (2004) Trends Pharmacol Sci , vol.25 , pp. 77-85
    • Douglas, S.A.1    Dhanak, D.2    Johns, D.G.3
  • 6
    • 0033638718 scopus 로고    scopus 로고
    • Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey
    • Douglas S.A., Sulpizio A.C., Piercy V., et al. Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey. Br J Pharmacol 131 (2000) 1262-1274
    • (2000) Br J Pharmacol , vol.131 , pp. 1262-1274
    • Douglas, S.A.1    Sulpizio, A.C.2    Piercy, V.3
  • 7
    • 18044392247 scopus 로고    scopus 로고
    • Urotensin II: a vascular mediator in health and disease
    • Kemp W., Roberts S., and Krum H. Urotensin II: a vascular mediator in health and disease. Curr Vasc Pharmacol 3 (2005) 159-168
    • (2005) Curr Vasc Pharmacol , vol.3 , pp. 159-168
    • Kemp, W.1    Roberts, S.2    Krum, H.3
  • 8
    • 0041331762 scopus 로고    scopus 로고
    • Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions
    • Watson A., Lambert G.W., Smith K.J., and May C.N. Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions. Hypertension 42 (2003) 373-379
    • (2003) Hypertension , vol.42 , pp. 373-379
    • Watson, A.1    Lambert, G.W.2    Smith, K.J.3    May, C.N.4
  • 9
    • 10744221258 scopus 로고    scopus 로고
    • Urotensin causes fatal circulatory collapse in anaesthetized monkeys in vivo: a vasoconstrictor with unique hemodynamic profile
    • Zhu Y.Z., Wang Z.J., Zhu J.C., et al. Urotensin causes fatal circulatory collapse in anaesthetized monkeys in vivo: a vasoconstrictor with unique hemodynamic profile. Am J Physiol Heart Circ Physiol 286 (2004) H 830-H 836
    • (2004) Am J Physiol Heart Circ Physiol , vol.286
    • Zhu, Y.Z.1    Wang, Z.J.2    Zhu, J.C.3
  • 10
    • 0037042532 scopus 로고    scopus 로고
    • Congestive heart failure and expression of myocardial urotensin II
    • Douglas S.A., Tayara L., Ohlstein E.H., Halava N., and Giaid A. Congestive heart failure and expression of myocardial urotensin II. Lancet 359 (2002) 1990-1997
    • (2002) Lancet , vol.359 , pp. 1990-1997
    • Douglas, S.A.1    Tayara, L.2    Ohlstein, E.H.3    Halava, N.4    Giaid, A.5
  • 12
    • 1542316805 scopus 로고    scopus 로고
    • Elevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathy
    • Lapp H., Boerrigter G., Costello-Boerrigter L.C., et al. Elevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathy. Int J Cardiol 94 (2004) 93-97
    • (2004) Int J Cardiol , vol.94 , pp. 93-97
    • Lapp, H.1    Boerrigter, G.2    Costello-Boerrigter, L.C.3
  • 13
    • 0242441544 scopus 로고    scopus 로고
    • Central cardiovascular action of urotensin II in spontaneously hypertensive rats
    • Lin Y., Tsuchinachi T., Matsumura K., et al. Central cardiovascular action of urotensin II in spontaneously hypertensive rats. Hypertens Res 26 (2003) 839-845
    • (2003) Hypertens Res , vol.26 , pp. 839-845
    • Lin, Y.1    Tsuchinachi, T.2    Matsumura, K.3
  • 14
    • 1642326840 scopus 로고    scopus 로고
    • Urotensin II: a novel systemic hypertensive factor in the cat
    • Behm D.J., Doe C.P., Johns D.G., et al. Urotensin II: a novel systemic hypertensive factor in the cat. Naunyn Schmiedebergs Arch Pharmacol 369 (2004) 274-280
    • (2004) Naunyn Schmiedebergs Arch Pharmacol , vol.369 , pp. 274-280
    • Behm, D.J.1    Doe, C.P.2    Johns, D.G.3
  • 15
    • 0142243355 scopus 로고    scopus 로고
    • A comparison of cerebrospinal fluid and plasma urotensin II concentrations in normotensive and hypertensive patients undergoing urological surgery during spinal anesthesia: a pilot study
    • Thompson J.P., Watt P., Sanghavi S., Strupish J.W., and Lambert D.G. A comparison of cerebrospinal fluid and plasma urotensin II concentrations in normotensive and hypertensive patients undergoing urological surgery during spinal anesthesia: a pilot study. Anesth Analg 97 (2003) 1501-1503
    • (2003) Anesth Analg , vol.97 , pp. 1501-1503
    • Thompson, J.P.1    Watt, P.2    Sanghavi, S.3    Strupish, J.W.4    Lambert, D.G.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.